The largest database of trusted experimental protocols

Ivis kinetic

Manufactured by PerkinElmer
Sourced in United States, France

The IVIS Kinetic is a high-performance in vivo imaging system designed for preclinical research. It enables non-invasive, real-time visualization and quantification of bioluminescent and fluorescent signals in living organisms. The system provides versatile imaging capabilities to support a wide range of applications in fields such as oncology, neuroscience, and infectious disease research.

Automatically generated - may contain errors

38 protocols using ivis kinetic

1

Quantifying Tumor Proliferation and Dissemination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proliferation and thoracic dissemination of 4T1 cells were quantified by in vivo bioluminescence imaging (IVIS Kinetic, PerkinElmer, Villebon-sur-Yvette, France) on days 7 and 14 following implantation. Five minutes before imaging, vigil mice received an intraperitoneal injection of 150 µg/g of d-luciferin. They were then anesthetized (isoflurane 4% for induction and 1.5% thereafter) and placed in the BLI system (IVIS Kinetic, PerkinElmer, Villebon-sur-Yvette, France), in supine position.
Signal quantifications were carried out by drawing regions of interest on the primary tumor and thorax areas (LivingImage software; PerkinElmer, Villebon-sur-Yvette, France). Results were expressed as photons per second (ph/s).
+ Open protocol
+ Expand
2

Lentivirus-Mediated Lymphoma Induction in Rag1-/- Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
For lentivirus production, 293T cells were co-transfected with the viral backbone vector, PMDG and gag-POL packaging vectors donated from Professor Ben-Neriyha's lab using Mirus-TransIT-293 transfection reagent according to standard protocol. EL4 cells were transduced with 5 ml lentivirus in the presence of (6 μg/ml) polybrene. Two days post-infection, puromycin (2.5 μg/ml) was added to the cells for another 1 day at 37°C for the selection of cells containing Slfn2 shRNA or scrambled shRNA. After selection, the cells were infected with the lentivirus containing luciferase donated from Dr. Granot's lab. A total of 6 × 105 infected cells were injected IP into Rag1−/− mice. The mice were monitored for lymphoma development by the IVIS Kinetic (Caliper Life Sciences) Bioluminescent Fast Imaging system at 13 and 20 days post-injection. Before imaging, the mice were injected with luciferin at 3 mg per mouse (Megapharm, catalog number: 82250).
+ Open protocol
+ Expand
3

In Vivo 2-DG Tumor Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
WT or 5-FU-R cell-bearing nude mice were injected with 10 nmol IRDye 800CW 2-DG Optical Probe (Li-Cor Biosciences) via the tail vein, and then imaged using an IVIS Kinetic (Caliper Life Sciences, USA) small animal imaging system with a cooled Hamamatsu ORCA-R2 camera (Hamamatsu, Japan) 24 h later. Probe signals were displayed as pseudo-colored bioluminescent images and merged with grey-scale white light images of the mice. Circular ROIs were drawn over the areas and quantified, and the results are reported as total radiant efficiency.
+ Open protocol
+ Expand
4

Xenograft Tumor Monitoring in Nude Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
2 × 106 A549 cells or 2.5 × 105 H460 cells expressing luciferase were injected subcutaneously into the right flank of 6-week old female athymic nude mice (Duke Breeding Core, Durham, NC, USA). Tumors were measured with calipers twice a week, and tumor volume was calculated as 0.5 × width2 × length. Mice were injected with 100uL of 15mg/mL luciferin and scanned weekly using an IVIS Kinetic (Caliper Life Sciences, Waltham, MA, USA) to assess bioluminescence. Tumors and any metastatic lesions were harvested, and necropsy was performed when tumors reached 2000 mm3 or at end of study. n=12 mice for each cell line for both A549 and H460 experiments were used for a power of 80%. All mice were 6-week old female athymic nude mice so no randomization was performed. Study complies with ethical regulations and approved by the Duke Institutional Animal Care and Use Committee (IACUC). Blinding was accomplished by assigning each mouse a unique identifier without annotation of experimental group. Only this identifier was known to investigators during caliper measurements.
+ Open protocol
+ Expand
5

Evaluating TRAIL-Mediated Cancer Cell Death

Check if the same lab product or an alternative is used in the 5 most similar protocols
5 × 103 cancer cells (MDA-MB231-Br or A549) labeled with stable expression of FLuc were seeded in 24-well plates in 10% FBS, 1% penicillin/streptomycin, and 0.01% Plasmocin DMEM. The following day, wells were seeded with varying numbers of hiNSC-TRAIL cells, from 0 to 10,000 cells/well. After 1, 3, and 7 days, viability of the cancer cells was assessed by adding 0.225 μg/mL XenoLight D-luciferin (PerkinElmer) and measuring luminescence using a SynergyH1 microplate reader (BioTek) at 1-sec per well measurement (N=4) or IVIS® Kinetic (Caliper Life Sciences) (N=4–8). Viability was determined by dividing the luminescent signal of these wells by their untreated counterparts at each time point. To test viability of hiNSCs after exposure to recombinant human TRAIL (Sigma), we incubated hiNSCs expressing FLuc with 1–500 ng/mL TRAIL for 48 hours before assessing luminescence on SynergyH1 microplate reader as described above.
+ Open protocol
+ Expand
6

Bioluminescent Imaging for Tumor and Stem Cell Tracking

Check if the same lab product or an alternative is used in the 5 most similar protocols
To follow tumor volume or hiNSC-mC-FLuc distribution and persistence, serial bioluminescent imaging (BLI) was performed as previously described (3 (link), 17 ). Mice were administered D-luciferin (3 mg per mouse in 200 μL of PBS) via intraperitoneal injection. 15 min following injection, photon emission was measured using Ami HT (Spectral Instruments Imaging) or IVIS® Kinetic (Caliper Life Sciences). Luminescence was quantified through analysis with Aura (Spectral Instruments Imaging).
+ Open protocol
+ Expand
7

Fluorescence Imaging and Image-Guided Surgery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluorescence imaging and image-guided surgery were performed with a method described previously.20 (link) Mice were subjected to fluorescence imaging using an IVIS Kinetic optical imaging system (Caliper Life Sciences, Alameda, CA, USA) right after the microPET scan at each time point. The parameters used during the imaging was 10s exposure time (f/stop=4) with an ICG filter set. Image-guided surgery was performed following fluorescence imaging at 48 h after I.V. injection.
+ Open protocol
+ Expand
8

In Vivo Tracking of Lipid Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
When the tumor volumes of the SMMC-7721-xenotransplanted BALB/c nude mice reached 200 mm3, LP-ERN-DiR or Tf-LP-ERN-DiR were injected into mice tail veins to give an ERN concentration of 2 mg/kg. The tissue distributions of LP-ERN-DiR and Tf-LP-ERN-DiR in the mice at 2 h, 4 h and 6 h after injection were observed using a small-animal in vivo imaging system (IVIS Kinetic, Caliper, Boston, MA, USA). Finally, the mice were euthanized, tissues were collected, and the fluorescence intensities of tissue types were observed and compared.
+ Open protocol
+ Expand
9

Xenograft Tumor Monitoring in Nude Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
2 × 106 A549 cells or 2.5 × 105 H460 cells expressing luciferase were injected subcutaneously into the right flank of 6-week old female athymic nude mice (Duke Breeding Core, Durham, NC, USA). Tumors were measured with calipers twice a week, and tumor volume was calculated as 0.5 × width2 × length. Mice were injected with 100uL of 15mg/mL luciferin and scanned weekly using an IVIS Kinetic (Caliper Life Sciences, Waltham, MA, USA) to assess bioluminescence. Tumors and any metastatic lesions were harvested, and necropsy was performed when tumors reached 2000 mm3 or at end of study. n=12 mice for each cell line for both A549 and H460 experiments were used for a power of 80%. All mice were 6-week old female athymic nude mice so no randomization was performed. Study complies with ethical regulations and approved by the Duke Institutional Animal Care and Use Committee (IACUC). Blinding was accomplished by assigning each mouse a unique identifier without annotation of experimental group. Only this identifier was known to investigators during caliper measurements.
+ Open protocol
+ Expand
10

Non-invasive Tumor Imaging Using CB Probe

Check if the same lab product or an alternative is used in the 5 most similar protocols
When the diameter of tumor xenografts reached 7.0±3.0 mm in size, 2 nmol (100 µl) of the CB probe was injected via tail vein following the probe manual. After injection, the anesthetized mice (n = 6) were placed in the heated imaging platform, the NIRF signals were non-invasively monitored using a living imaging system (IVIS Kinetic, Caliper Life Sciences, USA). Image acquisition parameters were as follows: emission filter  =  Cy5.5, excitation filter  = 675 nm, emission spectra  = 680 to 720 nm, exposure time  = 0.5 s, f/stop  = 2, binning  =  medium, field of view  = 12.5 cm2. In vivo imaging of tumor bearing mice were performed every 2 h, 36 h post the CB probe injection, and acquired images were analyzed using living image software (version 4.2.0, Caliper Life Sciences, Inc., US). Fluorescence intensity, defined as total radiant efficiency [p/s]/[μW/cm2], was quantified using identical size regions of interest (ROI). The tumor ROIs were placed with the center over the respective brightest fluorescence in the tumor xenografts. For consistency, the same investigator placed all ROIs. The data were shown as mean ± SD. Normal nude mice (n = 3) acted as control group.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!